1. Home
  2. PLNT vs EWTX Comparison

PLNT vs EWTX Comparison

Compare PLNT & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Fitness Inc.

PLNT

Planet Fitness Inc.

HOLD

Current Price

$48.32

Market Cap

4.2B

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$43.73

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLNT
EWTX
Founded
1992
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PLNT
EWTX
Price
$48.32
$43.73
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
$107.46
$39.00
AVG Volume (30 Days)
2.2M
1.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,324,144,000.00
N/A
Revenue This Year
$19.22
N/A
Revenue Next Year
$11.66
N/A
P/E Ratio
$38.47
N/A
Revenue Growth
12.06
N/A
52 Week Low
$37.03
$13.50
52 Week High
$114.26
$48.40

Technical Indicators

Market Signals
Indicator
PLNT
EWTX
Relative Strength Index (RSI) 32.87 56.41
Support Level $37.03 $37.50
Resistance Level $54.47 $44.93
Average True Range (ATR) 1.81 2.23
MACD -0.90 0.27
Stochastic Oscillator 5.83 76.02

Price Performance

Historical Comparison
PLNT
EWTX

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: